Legal status · United Kingdom
Is Elamipretide legal in the United Kingdom?
No. Elamipretide is not an approved medicine in the United Kingdom; its classification is "Not licensed". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Moderate.
Elamipretide in the United Kingdom at a glance
| Classification | Not licensed |
|---|---|
| MHRA approval status | Not approved by MHRA |
| Evidence level | Moderate (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Elamipretide profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
No product containing Elamipretide is approved by MHRA for any use in the United Kingdom, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United Kingdom. This page is general information, not legal advice.
What Elamipretide is
An investigational mitochondria-targeting peptide studied for rare mitochondrial disease and age-related organ decline.
Elamipretide concentrates in the inner mitochondrial membrane by binding cardiolipin, aiming to restore efficient energy production. It has been studied in clinical trials for primary mitochondrial myopathy, Barth syndrome, and dry age-related macular degeneration, with mixed results.
Mechanism: Binds cardiolipin in the inner mitochondrial membrane, stabilizing cristae structure and improving electron transport efficiency and ATP production.
Regulatory history: FDA-approved September 19, 2025 as Forzinity (accelerated approval) for Barth syndrome; other uses investigational
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Elamipretide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Elamipretide in other countries
Frequently asked questions
Is Elamipretide legal in the United Kingdom?
No. Elamipretide is not an approved medicine in the United Kingdom; its classification is "Not licensed". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Moderate.
Can I buy Elamipretide in the United Kingdom?
No approved product exists to buy. In the United Kingdom Elamipretide is classified as "Not licensed", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Elamipretide MHRA approved?
No. In the United Kingdom Elamipretide is classified as "Not licensed", which is not a MHRA marketing approval. For comparison, the US FDA status is: FDA-approved September 19, 2025 as Forzinity (accelerated approval) for Barth syndrome; other uses investigational. Evidence level: Moderate.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Elamipretide live on its compound profile.
Elamipretide profileThis page is general information about the regulatory status of Elamipretide in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.